Keytruda

Description

Keytruda.

metastatic melanoma or inoperable cases of this skin tumor;

non-small cell lung cancer, especially metastatic, having a high expression (manifestation) of the target receptor;

metastatic non-squamous non-small cell lung cancer in combination with chemotherapeutic agents;

recurrent and metastatic squamous cell carcinoma of the head and neck;

kidney cancer, including metastatic, with the ineffectiveness of chemotherapy;

inoperable or metastatic cancer of the internal organs with the ineffectiveness of chemotherapy;

gastric cancer, adenocarcinoma of the esophagus.

Active ingredient: pembrolizumab

Storage temperature 4-8 degrees

Prescription medicine.